<DOC>
	<DOCNO>NCT00725777</DOCNO>
	<brief_summary>Patients non-falciparum infection give artemether-lumefantrine three day follow 28 day . Besides efficacy safety evaluation substudy immunology perform .</brief_summary>
	<brief_title>Treatment Non-falciparum Malaria</brief_title>
	<detailed_description />
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Artemether-lumefantrine combination</mesh_term>
	<mesh_term>Lumefantrine</mesh_term>
	<mesh_term>Artemether</mesh_term>
	<mesh_term>Artemisinins</mesh_term>
	<criteria>Male female patient age 6 month 60 year minimum 5kg bodyweight Presence uncomplicated malaria confirm : ) fever history fever previous 4 day , ii ) positive microscopy P. malariae P. ovale mixed infection P.falciparum parasite density &gt; 50200000/Î¼l blood Written inform consent Patients presence clinical condition require hospitalization Presence febrile condition Presence significant anemia , define hemoglobin &lt; 7g/dl Known history hypersensitivity , allergic adverse reaction artemether lumefantrine Intake antimalarial antibiotic know antimalarial activity precede 2 week Pregnant breast feeding female</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2012</verification_date>
</DOC>